Add BrightSurf on Google Email

Drug development advances in beneficial loss-of-function (LOF) mutation targets validated by human genetics

Beneficial LOF mutations have been identified as potential targets for disease prevention, with drugs like PCSK9 inhibitors and ANGPTL3 monoclonal antibodies already approved or in clinical trials. New targets like ASGR1 and KHK are also being explored for lipid-lowering and fructose metabolism therapies.

SourceSichuan International Medical Exchange and Promotion Association·JournalMedComm·TypeSystematic review·DateMar 26, 2024

Chinese Medical Journal article unveils metabolic strategies to enhance CAR-T cell therapy

Researchers unveil innovative strategies to overcome metabolic constraints in CAR-T cell therapy, aiming to boost its efficacy in treating solid tumors. Metabolic interventions targeting immunosuppressive metabolites, metabolite uptake, and mitochondrial metabolism are proposed to enhance anti-tumor activity.

SourceCactus Communications·JournalChinese Medical Journal·TypeSystematic review·DateMar 26, 2024

Application of PROTACs in target identification and validation

Research progress in PROTAC technology is summarized, highlighting its role in target identification and validation. The article distinguishes between target identification and validation concepts to further promote the application of PROTAC tools.

SourceCompuscript Ltd·JournalActa Materia Medica·DateMar 24, 2024
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Fast folding for synthetic peptides and microproteins

Researchers at Xi'an Jiaotong-Liverpool University developed a new method that enables the efficient production of cysteine-rich peptides and microproteins in their naturally folded 3D structure. The approach uses organic solvents to mimic nature's oxidative folding process, resulting in speeds of over 100,000 times faster than aqueous...

SourceXi'an Jiaotong-Liverpool University·JournalAngewandte Chemie·TypeExperimental study·DateMar 21, 2024

A new path to drug diversity

A team of scientists discovered new fusion sites in protein evolution that enable faster and more targeted drug development. By combining evolutionary processes with synthetic biology, they created customized biological drugs with improved therapeutic properties.

SourceMax-Planck-Gesellschaft·JournalScience·DateMar 21, 2024
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence

Adding ribociclib to hormone therapy improves invasive disease-free survival by 90.4% at three years, distant disease-free survival by 90.8%, and recurrence-free survival by 91.7%. The study found a 25% relative reduction in recurrence rate for patients with stage 2 or 3 HR-positive, HER2-negative early breast cancer.

SourceUniversity of California - Los Angeles Health Sciences·JournalNew England Journal of Medicine·DateMar 20, 2024

“From Osimertinib to Preemptive Combinations” by Dr. Blagosklonny

Researchers propose combining osimertinib with gefitinib to increase progression-free survival rates in EGFR-mutant lung cancer patients. A comprehensive PC approach could dramatically boost PFS for 80% of patients, eliminating harm and improving treatment outcomes.

SourceImpact Journals LLC·JournalOncotarget·TypeCommentary/editorial·DateMar 19, 2024

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

A combination of short-course hormonal therapy and stereotactic body radiation therapy has been shown to be safe and effective in treating metastatic prostate cancer. In a preliminary study, 50% of patients remained recurrence-free six months after treatment, with less than a quarter experiencing severe side effects.

SourceUniversity of California - Los Angeles Health Sciences·JournalEuropean Urology·DateMar 18, 2024

Overeating and starving both damage the liver: Cavefish provide new insight into fatty liver disease

Researchers have identified a gene responsible for the development of starvation-induced fatty liver in cavefish, which are able to protect their liver due to reduced fat accumulation. This genetic basis has implications for understanding and addressing liver conditions in humans, including Type 2 diabetes and obesity.

SourceStowers Institute for Medical Research·JournalLife Science Alliance·TypeExperimental study·DateMar 18, 2024
Celestron NexStar 8SE Computerized Telescope

Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.

How a natural compound from sea squirts combats cancer

Researchers have deciphered trabectedin's precise mechanism of action, revealing its ability to induce persistent DNA breaks in cancer cells. This disruption of the transcription-coupled nucleotide excision repair (TC-NER) pathway leads to long-lasting DNA breaks that ultimately kill cancer cells.

SourceInstitute for Basic Science·JournalNature Communications·TypeExperimental study·DateMar 12, 2024
Apple Watch Series 11 (GPS, 46mm)

Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.

What makes a pathogen antibiotic-resistant?

A new study published in npj Antimicrobials and Resistance found that pathogenic bacteria E. coli and A. baumannii employ shared and unique mechanisms to acquire resistance to antibiotics ciprofloxacin and GP6. The researchers developed a method to track the acquisition of drug resistance using whole genome sequencing, which revealed t...

SourceSanford Burnham Prebys·Journalnpj Antimicrobials and Resistance·TypeExperimental study·DateMar 7, 2024
Meta Quest 3 512GB

Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.

University of Cincinnati study: Protein helps prevent breast cancer metastasis

Researchers at the University of Cincinnati Cancer Center have identified a new protein called p47 that helps prevent breast cancer metastasis. The study found that lower p47 expression was correlated with higher breast cancer metastasis, and that increasing p47 function could potentially lead to new therapies.

SourceUniversity of Cincinnati·JournalCell Reports·TypeSystematic review·DateMar 6, 2024

How does a diabetes drug lessen symptoms of depression?

Research has shown that dulaglutide, a diabetes drug, can reduce depressive-like behaviors in mice. The study identified four major pathways involved and linked markers of depression to lipid metabolism and tryptophan metabolism. This new perspective may facilitate the use of dulaglutide as a potential therapeutic strategy for depression.

SourceWiley·JournalBrain and Behavior·DateMar 6, 2024
Fluke 87V Industrial Digital Multimeter

Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.

Purdue researchers explore non-invasive method for sampling drug response

Purdue researchers have successfully isolated and detected drug-metabolizing enzymes from extracellular vesicles, which could enable personalized medicine by monitoring individual responses to prescription drugs. The method may also aid in detecting signs of Parkinson's disease and analyzing liver metabolism.

SourcePurdue University·JournalPNAS Nexus·TypeExperimental study·DateMar 5, 2024

Therapeutic targets in tumor microenvironment

The tumor microenvironment (TME) is a complex ecosystem surrounding tumors that impacts tumor development, metastasis, and responses to therapies. The review highlights potential therapeutic targets modulating TME components, including immune cells, stromal cells, and ECM proteins, to inhibit tumor progression.

SourceSichuan International Medical Exchange and Promotion Association·JournalMedComm – Oncology·DateMar 4, 2024

Proceed with caution – the meteoric rise of zero-alcohol drinks

A recent study by Flinders University found that parents are conflicted and concerned about zero-alcohol drinks due to their similarity in taste and appearance. The research suggests that providing these drinks to adolescents may normalize alcohol consumption, leading to increased risks of harm.

SourceFlinders University·JournalAustralian and New Zealand Journal of Public Health·TypeSurvey·DateMar 4, 2024

AGA announces 12-point plan to improve the care of all patients with inflammatory bowel disease (IBD)

The American Gastroenterological Association has proposed a 12-point plan to enhance IBD care in the US, focusing on insurer-mandated barriers such as prior authorization and step therapy. The plan aims to improve treatment access and quality for over three million Americans living with IBD.

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·TypeSystematic review·DateFeb 28, 2024
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)

Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.

Cannabis use linked to increase in heart attack and stroke risk

A new study found that frequent cannabis use is associated with a higher risk of heart attack and stroke, even after controlling for tobacco use and other cardiovascular risk factors. The study analyzed data from over 430,000 adults in the US and found that smoking cannabis was significantly linked to cardiovascular risks.

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateFeb 28, 2024

Innovative chemotherapy approach shows promise against lung cancer

A novel chemotherapy approach uses patient's own cells as Trojan horses to deliver targeted cancer-killing drugs to lung cancer cells. The method has shown promise in reducing tumor size and improving treatment efficacy with minimal collateral damage to healthy tissues.

SourceUniversity of Texas at Arlington·JournalBioactive Materials·TypeExperimental study·DateFeb 23, 2024

Immune cell receptor provides promising immunotherapy target

A new strategy used by cancer cells to protect themselves from immune system attack has been identified, and a potential target for immunotherapy has been found. Blocking activin receptor 1C on CD4+ T cells may help prevent the accumulation of immune-suppressing Tregs in tumors and slow tumor growth.

SourceJohns Hopkins Medicine·JournalOncoImmunology·DateFeb 22, 2024
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Mark Cuban Drug Company may offer savings for urology drugs

A new study suggests that Mark Cuban Cost Plus Drug Company (MCCPDC) may offer significant savings for patients taking common urology medications, with the greatest potential to reduce costs being for solifenacin and oxybutynin. The online pharmacy's standardized pricing can reduce out-of-pocket costs by up to $20 per prescription.

SourceWolters Kluwer Health·JournalUrology Practice·DateFeb 21, 2024

Researchers reveal mechanism of drug reactivating tumor suppressors

A team of researchers from the University of Tokyo demonstrated that a drug, valemetostat, reduces tumor growth in blood cancer by targeting H3K27me3, a protein modification silencing tumor suppressor genes. The treatment restores expression of many tumor suppressor genes and sustains inhibiting tumor cell growth.

SourceUniversity of Tokyo·JournalNature·TypeRandomized controlled/clinical trial·DateFeb 21, 2024
Kestrel 3000 Pocket Weather Meter

Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.

Nanoparticles containing natural substance treat visceral leishmaniasis with scant side effects

Researchers at São Paulo State University developed a novel technique using lipid nanoparticles to administer lupeol, killing Leishmania protozoan parasites. The therapy eliminated parasites from organs in animal tests, reducing spleen and liver parasite numbers by 99.9% with minimal side effects.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalPharmaceuticals·DateFeb 20, 2024

UCLA-led research results in FDA approval of 4-drug combination for frontline treatment of metastatic pancreatic cancer

A four-drug chemotherapy regimen, NALIRIFOX, has been approved by the FDA for frontline treatment of metastatic pancreatic adenocarcinoma. The regimen, combining irinotecan liposome, oxaliplatin, leucovorin, and fluorouracil, resulted in longer overall survival compared to a two-drug protocol.

SourceUniversity of California - Los Angeles Health Sciences·JournalThe Lancet·DateFeb 15, 2024
Apple AirPods Pro (2nd Generation, USB-C)

Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.

Double risk of dementia after mouth ulcer virus

A new study from Uppsala University found that people who have had herpes virus are twice as likely to develop dementia as those who have never been infected. The researchers studied 1,000 70-year-olds over 15 years and confirmed previous research on the potential link between herpes and dementia.

SourceUppsala University·JournalJournal of Alzheimer’s Disease·TypeObservational study·DateFeb 14, 2024

Study reveals mechanism that aggravates tuberculosis and reduces survival rates

Researchers found that an imbalance of CD4+ T cells in the lungs can exacerbate tuberculosis, leading to increased disease severity and reduced survival rates. Removing a specific receptor that recognizes extracellular ATP can improve the response of these T cells and potentially lead to new therapeutic interventions.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalCell Reports·DateFeb 8, 2024

Study shows clinical benefit of new way of treating advanced ER+ breast cancer

A new study published in The Lancet Oncology demonstrates that the drug enobosarm has anti-tumour effects in oestrogen receptor positive breast cancer patients, providing a novel approach to treatment. The study showed that enobosarm was well tolerated with no significant impact on quality of life.

SourceUniversity of Liverpool·JournalThe Lancet Oncology·TypeRandomized controlled/clinical trial·DateFeb 8, 2024
Rigol DP832 Triple-Output Bench Power Supply

Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.

How T cells combat tuberculosis

Researchers at La Jolla Institute for Immunology have identified 137 unique T cell epitopes targeted by the immune system in patients with active TB. These findings may lead to the development of new diagnostics and therapies for the disease, which affects over 1.3 million people worldwide.

SourceLa Jolla Institute for Immunology·JournalNature Communications·TypeExperimental study·DateFeb 6, 2024

New weight loss medication may help lower blood pressure in adults with obesity

A new study published in the American Heart Association journal Hypertension found that tirzepatide significantly lowered systolic blood pressure levels in nearly 500 adults with obesity. The results suggest treating obesity with this weight loss medication may be an effective strategy for preventing or treating high blood pressure.

SourceAmerican Heart Association·JournalHypertension·DateFeb 5, 2024
Nikon Monarch 5 8x42 Binoculars

Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.

New approach to the design of therapies that enhance the effect of cholesterol-lowering drugs

Researchers discovered that reducing cholesterol levels in mice with advanced atherosclerosis leads to a decrease in the number of smooth muscle-derived cells causing plaque growth, while preserving stabilizing cell types. This finding opens up new opportunities for targeted therapies.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalNature Cardiovascular Research·TypeExperimental study·DateFeb 1, 2024

Diabetes medication class tied to lower risk of kidney stones

Researchers found that SGLT2 inhibitors reduced kidney stone rates by 30% compared to GLP1 agonists and 25% compared to DPP4 inhibitors. The study included data from 716,406 adults with type 2 diabetes who took these medications.

SourceMass General Brigham·JournalJAMA Internal Medicine·TypeData/statistical analysis·DateJan 31, 2024
CalDigit TS4 Thunderbolt 4 Dock

CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.

Researchers discover why one type of chemotherapy works best in bladder cancer

Researchers discovered that cisplatin chemotherapy enhances the immune system's ability to fight bladder cancer by modulating the immune response and damaging DNA in cancer cells. This approach may lead to durable disease control in a subset of patients with metastatic bladder cancer.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalCell Reports Medicine·DateJan 26, 2024

Study: UAB researchers establish optimal immunosuppression regimen for pig-to-human kidney transplants

Researchers found combining common immune-suppressing drugs with a complement inhibitor effectively managed the initial human immune response against transplanted pig kidneys. The regimen, which relies solely on already FDA-approved medications, showed remarkable success in Parsons model case series.

SourceUniversity of Alabama at Birmingham·JournalJournal of Clinical Investigation·TypeCase study·DateJan 25, 2024

MU study shows blood pressure drug can reduce anxiety for people with autism

A new study found that propranolol, a medication for high blood pressure, can lower anxiety levels in individuals with autism spectrum disorder. The study involved 69 patients and showed significantly reduced anxiety levels compared to a placebo group.

SourceUniversity of Missouri-Columbia·JournalPsychopharmacology·TypeRandomized controlled/clinical trial·DateJan 23, 2024

Could two drugs be better than one for treating prostate cancer?

A Phase 3 clinical trial found that combining testosterone-blocking drugs prevents cancer spread and extends treatment time in patients with relapsed prostate cancer. The approach is more effective than single-drug treatment in delaying cancer progression.

SourceUniversity of California - San Francisco·JournalJournal of Clinical Oncology·DateJan 23, 2024
Apple MacBook Pro 14-inch (M4 Pro)

Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.

Dr. Blagosklonny’s battle with cancer (Part 1)

Dr. Mikhail V. Blagosklonny, a renowned oncologist, shares his personal journey with metastatic brain cancer and challenges conventional treatment approaches. He argues that targeted drugs alone cannot cure lung cancer, but preemptive combinations may offer hope.

SourceImpact Journals LLC·JournalOncoscience·TypeCommentary/editorial·DateJan 22, 2024

Targeting annexin-A1 can halt cancer cell growth

A new study published in Oncogene highlights the effectiveness of MDX-124, a therapeutic drug targeting annexin-A1, which promotes tumour progression. High annexin-A1 expression levels correlate with poorer overall survival in various cancers.

SourceAnglia Ruskin University·JournalOncogene·TypeRandomized controlled/clinical trial·DateJan 19, 2024

Reductive carboxylation of glutamine as a potential target in AML

Researchers discuss reductive carboxylation of glutamine as a potential target in acute myeloid leukemia (AML), an aggressive cancer with poor patient outcomes. The approach aims to weaken tumor cell survival mechanisms, potentially leading to novel therapies and improved patient outcomes.

SourceImpact Journals LLC·JournalOncotarget·TypeCommentary/editorial·DateJan 16, 2024
Sony Alpha a7 IV (Body Only)

Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.

Spying on a shape-shifting protein

Scientists at the Advanced Science Research Center used X-ray crystallography with elevated temperature and pressure to observe distinct shapes in a protein molecule. The study reveals how proteins change shape to bind metabolites or other proteins, offering insight into disease treatment and development of novel drugs.

SourceAdvanced Science Research Center, GC/CUNY·JournalCommunications Biology·TypeImaging analysis·DateJan 12, 2024

New immune system-targeting compounds shows early promise in treating lupus

Researchers from Scripps Research have developed a small molecule that blocks the activity of SLC15A4, a protein linked to autoimmune diseases like lupus and Crohn's disease. The compound, FFF-21, successfully reduced inflammation in mouse models and isolated cells from people with lupus.

SourceScripps Research Institute·JournalNature Chemical Biology·DateJan 11, 2024

Newly identified genes for depression may lead to new treatments

A global study has identified over 200 genes linked to depression, including 50 new genetic loci and 205 novel genes. The research also suggests potential for drug repurposing and highlights the need for more diverse genetic datasets to develop effective treatments.

SourceUniversity College London·JournalNature Genetics·DateJan 10, 2024